Aminosalicylic Acid
Generic Name: aminosalicylic acid
Manufactured by ADAPTIS. Dosage form: GRANULE, DELAYED RELEASE. Route: ORAL. Active ingredients: AMINOSALICYLIC ACID (4GM/PACKET). Application: ANDA074346.
Overview
Manufactured by ADAPTIS. Dosage form: GRANULE, DELAYED RELEASE. Route: ORAL. Active ingredients: AMINOSALICYLIC ACID (4GM/PACKET). Application: ANDA074346.
Dosage
Available as granule, delayed release for oral use.
Related Medications
Risedronate Sodium
risedronate sodium
11 DESCRIPTION Risedronate sodium tablets, USP are pyridinyl bisphosphonates that inhibit osteoclast-mediated bone resorption and modulate bone metabolism. Each risedronate sodium tablet, USP for oral administration contains the equivalent of 35, 75, or 150 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate. The empirical formula for risedronate sodium hemi-pentahydrate is C 7 H 10 NO 7 P 2 Na •2.5 H 2 O.
Aluminum Hydroxide, Magnesium Hydroxide, And Dimethicone
aluminum hydroxide, magnesium hydroxide, and dimethicone
Purpose Antacid/Antigas
Sodium Borate, Oyster Shell Calcium Carbonate Crude, Calcium Fluoride, Tribasic Calcium Phosphate, Eupatorium Perfoliatum Flowering Top, Iron, Hydrofluoric Acid, Hekla Lava, Toxicodendron Pubescens Leaf, Ruta Graveolens Flowering Top, Silicon Dioxide, Comfrey Root.
sodium borate, oyster shell calcium carbonate crude, calcium fluoride, tribasic calcium phosphate, eupatorium perfoliatum flowering top, iron, hydrofluoric acid, hekla lava, toxicodendron pubescens leaf, ruta graveolens flowering top, silicon dioxide, comfrey root.
USES: Temporarily relieves bone aches and pains.**
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.